Jaguar Animal Health
Presença
Executivos
Veja o organograma con seus 21 executivos principais
Biografias mais buscadas da Jaguar Animal Health
- Lisa Conte, Chief Executive Officer, Executive Director
- John Micek, Director
- James Bochnowski, Chairman of the Board
Recentes movimentos de executivos em Jaguar Animal Health
- Massimo Radaelli, ingressou na Companhia como President of International (Notícia publicada em 3 de abril de 2024).
Criar um alerta
para seguir os movimentos de executivos da Jaguar Animal Health.
Farmacêutica
Jaguar Animal Health possui 1.859 concorrentes concorrentes Pfizer (Estados Unidos), Johnson & Johnson (Estados Unidos) e Sanofi (França).
Popular M&A news in Farmacêutica
- LakeShore Biopharma mudará seu nome para LakeShore Biopharma em May 24, 2024. (publicado em 25 de maio de 2024).
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Jaguar Animal Health
- Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
- Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
- Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
- Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
- Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
- Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
- Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
- Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
- Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
- Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
- View more press releases Close
Redes sociais sobre Jaguar Animal Health
- Jaguar Animal Health na Wikipedia, Google News e Yahoo Finance
- Jaguar Animal Health na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Lisa Conte 
Ligue para a Jaguar Animal Health em +1 415...
